Combined effect of ADH1B RS1229984, RS2066702 and ADH1C RS1693482/ RS698 alleles on alcoholism and chronic liver diseases. by Tóth, Réka et al.
Toth, Reka; Fiatal, Szilvia; Petrovski, Beata; McKee, Martin; Adany,
Roza (2011) Combined effect of ADH1B rs1229984, rs2066702 and
ADH1C rs1693482/rs698 alleles on alcoholism and chronic liver dis-
eases. DISEASE MARKERS, 31 (5). pp. 267-277. ISSN 0278-0240
DOI: https://doi.org/10.3233/DMA-2011-0828
Downloaded from: http://researchonline.lshtm.ac.uk/4650438/
DOI: 10.3233/DMA-2011-0828
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Disease Markers 31 (2011) 267–277 267
DOI 10.3233/DMA-2011-0828
IOS Press
Combined effect of ADH1B rs1229984,
rs2066702 and ADH1C rs1693482/ rs698
alleles on alcoholism and chronic liver
diseases
Re´ka To´tha,b, Szilvia Fiatala,b, Bea´ta Petrovskia, Martin McKeec and Ro´za A´da´nya,b,∗
aUniversity of Debrecen, Medical and Health Science Center, Faculty of Public Health, Department of Preventive
Medicine, Debrecen, Hungary
bPublic Health Research Group of the Hungarian Academy of Sciences, Faculty of Public Health, Medical and
Health Science Centre, University of Debrecen, Debrecen, Hungary
cLondon School of Hygiene and Tropical Medicine, London, UK
Abstract. The aim of this study was to analyze the combined effect of the most frequent alcohol dehydrogenase polymorphisms
(Arg48His and Arg370Cys in ADH1B, Arg272Gln and Ile350Val in ADH1C) on the alcohol use habits, alcohol dependence and
chronic liver diseases in Hungary.
The study included men, aged 45–64 years. Altogether, 241 cases with chronic liver disease (CLD) and 666 randomly selected
controls without CLD were analysed for all four polymorphisms. Associations between the polymorphisms, individually, and in
combination, and excessive and problem drinking and CLD, were assessed using logistic regression.
In this study we have identified a novel mutation, called ADH1B Arg370His. The ADH1C Arg272Gln and Ile350Val showed
almost complete linkage. The 272Gln/350Val allele increased the risk of excessive and problem drinking in homozygous form
(OR = 1.582, p = 0.035, CI = 1.034–2.421, OR = 1.780, p = 0.016, CI = 1.113–2.848, respectively). The joint analysis
showed that when combined with the wild type ADH1C Arg272/Ile350 allele, the ADH1B 48His is protective against CLD
(OR = 0.368, p = 0.019, CI = 0.159–0.851).
The results obtained in the study help not only to clarify the effects of different ADH SNPs but to better understand how these
polymorphisms modify each other’s effects in the development of alcoholism and related diseases.
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1. Introduction
The burden of alcohol-related disease is especially
high in the countries of Central and Eastern Europe [1].
In Hungary, the mortality from cirrhosis is more than
3 times higher than in Western European countries [2].
The risk of alcohol dependency (AD) and chronic liver
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diseases (CLDs), at an individual level, is affected by
genetic factors [3].
Ingested alcohol is mainly metabolized in the liv-
er, where the first step of oxidative degradation to ac-
etaldehyde, is catalysed by the alcohol dehydrogenases
(ADHs) mainly those in Class I [4]. Since the alde-
hyde dehydrogenase, catalysing the oxidation of ac-
etaldehyde to acetate, has a low Km, the acetaldehyde
produced is eliminated shortly after being formed [5].
Class I ADHs consist of α, β and γ subunits, encoded
by the genes ADH1A, ADH1B, and ADH1C. Single
nucleotide polymorphisms (SNPs) have been described
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in bothADH1B andADH1C that modify the enzymatic
properties.
The ADH1B Arg48His allele (rs1229984) gives rise
to theβ2 subunitwith a 40-fold higherVmax in homozy-
gous form than the β1 subunit that is encoded by the
wild allele. The ADH1B Arg370Cys (rs2066702) en-
codes the β3 subunit. In its homodimer form, it has 30-
fold higher Vmax than β1 [4,6]. The wild type ADH1C
(γ1 subunit) contains arginine at 272nd and isoleucine
at 350th position, while the ADH1C rs1693482/ rs698
variant, which encodes the γ2 subunit, contains glu-
tamine (rs1693482) and valine (rs698), respectively.
TheVmax of γ1 is 2–2.5 times higher than that of γ2 [4].
These two SNPs are in high linkage disequilibrium [7].
Variants with higher activity (γ1, β2 and β3) are con-
sidered to give rise to acetaldehyde accumulation via
faster ethanol degeneration, leading to adverse effects
such as facial flushing, nausea and tachycardia [4,7].
These effects may deter further drinking, but if individ-
uals persist with alcohol consumption, hepatotoxicity
and other tissue damage may occur [3,4,7].
Meta-analyses [8,9] have concluded that ADH1B
Arg48 allele is associated with a significantly increased
risk of alcoholism but is protective against liver disease
only in Asian populations. ADH1C 272Gln/350Val al-
lele seems to have little or no effect on alcoholism or
liver disease in European populations. The difference
between Asian and Caucasian populations may arise
from the presence of different haplotypes [10].
The frequency of the polymorphic alleles varies
among geographical regions. The ADH1B 48His allele
is relatively rare in Caucasians with a frequency of 0–
10% [6,11–15] except in Russia where one study found
it in 41% [16]. This allele is more frequent among
Asian populations, where its frequency varies from 50
to 90 percent, depending on ethnicity [15,17]. The
ADH1B 370Cys allele is mainly found among African
Americans, with a prevalence of 10–35% but it is rare
or absent in Caucasian and Asian populations [6,10].
ADH1C 272Gln/350Val allele frequencies range
from about 30 to 50% in Caucasians and strongly varies
in Asian populations [6,11–14,17].
Although there has been considerable research
among Caucasians on the effects of these SNPs in the
recent years, only one study [18] analysed the com-
bined effects of these polymorphisms, using only one
outcome in each analysis, alcohol use or dependence.
Moreover, almost all studies only investigated patients
with alcoholic liver disease and alcoholic controls. In
this study we describe not only the combined effect of
the most frequent ADH polymorphisms both on CLDs,
AD and alcohol use but with including non-alcoholic
cases and controls, we can also assess the possible ef-
fect of these polymorphisms on CLDs in moderate or
rare drinkers. The results help not only to an improved
understanding of the high prevalence of chronic liver
disease in Hungary but it may contribute to better un-
derstanding of how these polymorphisms modify each
other’s effects in relation to alcohol consumption and
liver disease.
2. Materials and methods
2.1. Sample recruitment
Subjects were recruited from 57 general practices
in four Hungarian counties (Gyo¨r-Moson-Sopron, Za-
la, Hajdu´-Bihar and Szabolcs-Szatma´r-Bereg) partici-
pating in the General Practitioners’ Morbidity Sentinel
Stations Program [19]. The present study was restrict-
ed to men, aged 45-64 years. Cases were all subject
identified as having chronic liver diseases while con-
trols were selected at random from those with no diag-
nosed CLDs. The case definition, described previous-
ly [20], is the presence of at least two of the following
pre-specified criteria based on physical examination:
spider naevi; ascites; palmar and plantar erythema;
jaundice; enlarged, firm liver with rounded or nodular
edge; and at least one of the following laboratory find-
ings: increased level of serum bilirubin, elevated aspar-
tate transferase activity, elevated alanine transferase ac-
tivity, elevated gamma-glutamyl-transpeptidase activi-
ty, elevated alkaline-phosphatase activity, or decreased
serum albumin. These physical and laboratory exam-
inations were conducted both on case and control pa-
tients. Where the findings of the tests were contra-
dictory with the previous diagnosis, patient was trans-
ferred to the proper group according to the test results.
Among cases, more than 65% were previously diag-
nosed by hepatologists, where the image examinations
(ultrasound, CT, MRI) and liver biopsy were used to
confirm the diagnosis. In case of the newly identified
cases, the diagnostic tests were conducted also by spe-
cialists. In our study only screening, not diagnostic ex-
aminations were carried out just to define the presence
or absence of liver diseases. Patients with hepatitis B or
hepatitis C infection were excluded from the analysis.
The patients were not screened for Cytomegalovirus
or Epstein-Barr virus infections in the framework of
the study; their serological status was classified later,
during the detailed diagnostic examinations. The final
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study population contained 666 controls and 241 cas-
es. The age distribution of controls was representa-
tive for the overall population (p = 0.424) and cases
were significantly older than controls (55.17 years vs.
53.89 years, respectively, p = 0.0023).
EDTA anti-coagulated blood samples were taken by
general practitioners for routine biochemical tests and
genotyping. Written informed consent was obtained
from each patient. The study was approved by the
Regional and Institutional Ethics Committee, Medical
and Health Science Center, University of Debrecen.
The study protocol conformed to the ethical guidelines
of the 1975 Declaration of Helsinki.
2.2. Questionnaire-based data collection
Detailed information on alcohol consumption was
gatheredusing a self-completedquestionnaire, yielding
the following variables.
Frequency of drinking, with seven possible out-
comes: (i) has never drunk alcohol, (ii) didn’t drink
in the last twelve months, (iii) drinks less than once
a month, (iv) drinks 1 to 3 times in a month, (v) 1 to
2 times in a week, (vi) 3 to 4 times in a week and (vii)
at least 5 times in a week.
Summary drinking data, in 4 categories: (i) non-
drinker; (ii) infrequent drinker, consuming alcohol less
than 3 times per month, independently from the quan-
tity of the consumed alcohol; (iii) moderate drinker,
if consumption is at least weekly, the weekly total is
14 units or less, and the daily amount is nevermore than
5 units; (iv) heavy drinker, if more than 14 units are
consumed weekly or if the amount more than 5 units is
consumed on at least one day of a week (1 unit = 15 g
pure ethanol).
CAGE score, from 0 to 4, according to the number of
positive answers on the CAGE questionnaire, a widely
used tool to detect problem drinking [21].
CAGE status is negative if the number of positive
answers on the CAGE questionnaire is 0 or 1, and
positive if it is 2 or more.
Patterns of alcohol use and demographic, financial
and educational characteristics in this sample have been
published previously [22]. In the present study we
analysed data only obtained on samples genotyped for
all the 4 polymorphisms.
Education is categorised from 0 to 3, where 0 signi-
fies an individual with 8 years of education or less, 1
signifies having attended secondary school without do-
ing the school leaving exam, 2 and 3 signify completed
secondary and higher education, respectively.
Financial status (self-assessed) has 3 possible val-
ues: 0 (bad/ very bad), 1 (adequate) and 2 (good/ very
good). This has been found to have greater validity
than questions on income or wealth in studies in this
region [23].
Demographic, financial and educational characteris-
tics and alcohol use habits of the study population are
shown in Table 1.
2.3. Genotyping
DNA was isolated from leukocytes with the use of
MagNA Pure LC DNA Isolation Kit – Large Volume
(Roche Diagnostics GmbH, Mannheim, Germany) ac-
cording to the manufacturer’s instructions. Genotyping
was performed on LightCycler real time PCR System
(Roche Diagnostics GmbH, Mannheim, Germany) by
melting curve analysis.
The genotyping for ADH1B Arg48His (rs1229984)
was performed as described previously [22]. ADH1C
Arg272Gln (rs1693482) and Ile350Val (rs698) poly-
morphismswere screened together in a duplex reaction,
while ADH1B Arg370Cys (rs2066702) was analysed
separately. Sequencing, where needed, was conducted
by Biomi Ltd., Hungary, with one of the adequate PCR
primers. The LightCycler reactions were performed
with LightCyclerDNA Master HybProbe (RocheDiag-
nostics, GmbH, Mannheim, Germany, Cat. No. 12 015
102 001), according the manufacturers’ instructions.
The probes applied in the melting curve analysis were
used in 0.2 μmol/l concentrations, while the primers
were in 0.5 μmol/l concentrations. The sequence of the
primers, probes and the reaction conditions are shown
in the Table 2.
2.4. Statistical analyses on samples used for:
2.4.1. Single SNP analysis
Logistic regression calculating odds ratios (ORs)was
applied to test the association between each genotype
and the outcome variables, presence of chronic liver
disease, frequency of drinking, summary drinking data,
number of positive CAGE answers given and CAGE
status. Results were adjusted for age, financial and
educational status. Where variables were non-binary,
ordered logistic regression was used which is appro-
priate to estimate the relationship between an ordinal
dependent variable and a set of independent variables.
With the ADH1B Arg48His and the newly identified
ADH1B Arg370His, the dominant model was used by
virtue of the low number of homozygous mutant sam-
ples while for ADH1C Arg272Gln and Ile350Val the
additive model proved the best fit.
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Table 1
Demographic, educational, financial characteristics and alcohol use in the study population
Controls Cases
Age Mean ± SD 53.89 ± 5.59 55.17 ± 5.49
Education
Data availability (n) 659 239
% %
8 years of education 21.85 28.87
Secondary school without exam 42.64 49.37
Secondary school 21.70 17.15
Higher education 13.81 4.60
Financial status
Data availability (n) 662 241
% %
Bad/very bad 16.92 22.82
Adequate 68.13 67.22
Good/very good 14.95 9.96
Frequency of drinking
Data availability (n) 644 236
% %
Never 13.66 7.20
Did not drink in the last 12 month 2.80 3.39
Less than 1 time in a month 7.14 2.54
1–3 times in a month 13.04 3.39
1–2 times in a week 22.20 6.78
3–4 times in a week 15.84 17.80
At least 5 times a week 25.31 58.90
Summarised drinking data
Data availability (n) 625 212
% %
Non-drinker 20.16 13.68
Infrequent drinker 11.20 4.72
Moderate drinker 21.44 13.68
Heavy drinker 47.20 67.92
Number of positive CAGE answers given
Data availability (n) 538 201
% %
0 55.20 15.42
1 18.03 18.41
2 10.59 19.40
3 9.67 27.36
4 6.51 19.40
CAGE status
Data availability (n) 538 201
% %
Negative 73.23 33.83
Positive 26.77 66.17
2.4.2. Linkage analysis
To map the linkage between the SNPs, LD, D’ and r2
values were calculated using Haploview Software [24].
2.4.3. Multivariate SNP analysis
To detect the combined effect of the three main
polymorphisms (48His, 272Gln, 350Val) and the pos-
sible epistasis between them, they were entered into
a multivariate logistic regression model. Altogether,
five groups were formed according to the genotype
status of the polymorphisms investigated: the sam-
ples in the first group (named wild/wild) were ho-
mozygous wild for all three mutations and served as
reference group; in the second (wild/heterozygous)
they were wild for Arg48His and heterozygous for
Arg272Gln and Ile350Val; the members of the third
group (wild/mutant) were also wild for Arg48His, but
homozygous mutant for Arg272Gln/ Ile350Val; the
fourth group (heterozygous/wild) contained carriers for
48His and wild samples for Arg272Gln/ Ile350Val,
while the fifth group (heterozygous/heterozygous)was
formed from samples carrying the 48His allele andwere
heterozygous for Arg272Gln/ Ile350Val (Table 3).
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Table 3
Genotypes of polymorphisms in groups used for multivariate SNP analysis
ADH1B Arg48His ADH1C Arg272Gln ADH1C Ile350Val
First group
(wild/wild)∗
homozygous wild homozygous wild homozygous wild
Second group
(wild/heterozygous)
homozygous wild heterozygous heterozygous
Third group
(wild/mutant)
homozygous wild homozygous mutant homozygous mutant
Fourth group
(heterozygous/wild)
heterozygous homozygous wild homozygous wild
Fifth group
(heterozygous/heterozygous)
heterozygous heterozygous heterozygous
∗served as reference type.
Any other combinations of these mutations and
the other polymorphisms involved in this study were
present in such a low number as to generate potentially
ambiguous results, therefore they were excluded from
the analyses. Logistic regression was used to measure
the association between these genotype combinations
and CLDs or alcohol consumption habits. Results
are expressed with both 95% confidence intervals and p
values at the 5% significance level. Data were analysed
using STATA 10.0 statistical software (StataCorp LP,
Texas, USA).
3. Results
Data on alcohol use and the demographic, financial
and educational characteristics of the study population
have been shown previously in Table 1.
3.1. Single SNP analysis
3.1.1. Identification of a new SNP variant
During the analysis of the ADH1B Arg370Cys
(rs2066702) mutation an unexpected polymorphism
was detected, causing approximately 2◦C lowering in
the melting temperature compared to the wild type (the
probe was specific for the mutant type). Sequencing
revealed this to be a recently identified gene variant in
which the same amino acid is affected but with substi-
tution of histidine instead of cysteine. This variant is
Arg370His (rs75967634), caused by a G to A substitu-
tion in the 1193rd mRNA position. Figure 1 shows the
results of the sequencing. Although this mutation has
been submitted recently to PubMed’s SNP database, no
data are yet available on its frequency or its effect, so it
was included in the further analysis. It was present in
1.98% of the study population.
3.1.2. Analysing the included SNPs
The allele frequencies and genotype frequencies of
ADH polymorphic regions studied are shown in Ta-
ble 4. Allmutations examinedwere inHardy-Weinberg
equilibrium in both cases and controls.
Odds ratios were calculated by using data obtained
on samples analysed for all 4 polymorphisms (Table 5).
Carriage of the ADH1B 48His allele was associat-
ed with significantly lower odds ratio for drinking fre-
quency, the number of positive answers on CAGE as-
sessment, and positive CAGE status. There was a sig-
nificant association between ADH1B 48His and CLDs,
but it disappeared after adjusting for CAGE status and
scores (OR = 0.61, p = 0.101; OR = 0.63, p = 0.123,
respectively).
The ADH1B 370His allele was not associated with
any of the examined outcomes.
The ADH1B Arg370Cys was excluded from further
analysis as a consequence of its low frequency (< 1%).
The frequency of ADH1C 272Gln was almost the
same as ADH1C 350Val and there were only two sam-
ples with different genotypes for these two mutations
(Table 4) therefore they were excluded from further
analysis and the effect of these polymorphisms were
calculated together in the single SNP analysis. These
two mutations showed no association with CLDs, but
they were associated with increased odds ratio for fre-
quency of drinking, summary drinking data and CAGE
status. However, these associations were only signifi-
cant when the mutations were homozygous.
The results of the single SNP analyses can be seen
in Table 5.
3.2. Linkage analysis
The results of the linkage analysis and the frequency
of the main haplotypes are shown in Fig. 2. As ex-
pected, there is a very high linkage between the two
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Fig. 1. The results of the sequencing of the ADH1B Arg370Cys/Arg370His polymorphism. Part A shows the coding sequence of a sample
heterozygous for 370Cys, while on part B, the sequence coding a heterozygous 370His variant can be seen. Part C represents the wild type
(homozygous for Arg370).
ADH1C mutations. The high D’ combined with the
low r2 values in case of ADH1C 272Gln and 350Val
versus ADH1B 48His indicate that the combination
of wild-wild-mutant and mutant-mutant-wild alleles is
more frequent in the population than could be expected
from the allele frequencies themselves.
3.3. Multivariate SNP analysis
The results of the multivariate analysis are shown in
Table 6.
For drinking habits, only the frequency of drinking
was significantly associatedwith the heterozygous/wild
group, with an odds ratio of 0.550 (p = 0.011, CI =
0.346–0.874).
There was no significant difference for either the
summary drinking data or the number of positiveCAGE
answers.
Both wild/heterozygous and wild/mutant groups re-
sulted in higher odds ratios for positive CAGE status
(OR = 1.540, p = 0.024, CI = 1.058–2.241; OR =
1.859, p = 0.014, CI = 1.136–3.042). Interesting-
ly, neither the heterozygous/wild, nor the heterozy-
gous/heterozygous showed difference for CAGE sta-
tus.
Significant association with CLDs was found on-
ly in case of groups containing the mutant allele for
Arg48His. Both appeared to be protective, with odds
ratios of 0.398 (heterozygous/wild, p = 0.010, CI =
0.197–0.806) and 0.461 (heterozygous/heterozygous,
p = 0.043, CI = 0.218–0.975).
To clarifywhether these combinations act directly on
the risk of chronic liver disease or via drinking habits
(i.e. CAGE status), these outcome variables were en-
tered together into a logistic regression model to as-
sess their effect when controlling for the other out-
come variable. When CAGE status was used as out-
come and the presence of chronic liver disease was ad-
justed for, the association with wild/heterozygous and
wild/mutant groups remained significant (OR= 1.756,
p = 0.006, CI= 1.171–2.633; OR= 2.204, p = 0.004,
CI = 1.287–3.774). When CLD was used as a de-
pendent variable and results were adjusted for CAGE
status, only the effect of the heterozygous/wild group
on CLD remained significant (OR= 0.368, p = 0.019,
CI = 0.159–0.851).
To assess the possible effects of these combinations
onCLDs amongnon-alcoholics, we entered them into a
logistic regression model restricted only to CAGE neg-
ative cases and controls. Only the heterozygous/wild
group showed significant association with CLDs
(OR = 0.116, p = 0.039, CI = 0.015–0.900).
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Table 4
Genotype and allele frequencies of the polymorphisms studied
Allele frequency Genotype frequency
wt mt wt/wt wt/mt mt/mt
Cases Cont. Cases Cont. Cases Cont. Cases Cont. Cases Cont.
ADH1B Arg48His
(rs1229984)
0.956 0.914 0.044 0.086 0.913 0.832 0.087 0.165 0.000 0.003
ADH1B Arg370His
(rs75967634)
0.990 0.990 0.010 0.010 0.979 0.981 0.021 0.020 0.000 0.000
ADH1B Arg370Cys
(rs2066702)
1.000 0.999 0.000 0.001 1.000 0.997 0.000 0.003 0.000 0.000
ADH1C Arg272Gln
(rs1693482) / Ile350Val
(rs698)
0.613 0.613 0.387 0.387 0.375 0.367 0.475 0.492 0.150 0.141
wt = wild type, mt = mutant type, cont. = controls.
Fig. 2. The results of the linkage analysis. The upper part shows the LD plot, where the intensity of the colour indicates the D’/LOD values. The
lower part contains the D’, LOD and r2 values between the SNPs.
4. Discussion
Although there have been recent declines, death rates
from chronic liver diseases and cirrhosis remain much
higher in the majority of the Central-Eastern European
countries – among them Hungary – than in the coun-
tries of western Europe. In previous years, the potential
role of the quality of alcohol consumed in this region
has been examined [25,26] but potential genetic factors
have received less attention. Although research has
been conducted in other European countries [12–14,16,
18,27–32], the combined effects of the main polymor-
phisms remain to be clarified. In a previous study [22],
we have taken a first step by mapping the prevalence
of ADH1B Arg48His in Hungary. In this study, our
goal was not only to wider this investigation to other,
also important SNPs, but to examine their joint impacts
on chronic liver diseases, alcohol dependence and al-
cohol drinking habits not only among alcoholic cases
and controls but among moderate and rare drinkers as
well. The results of this complex analysis begin to of-
fer insights into the genetic background of alcohol con-
sumption and alcohol-related diseases not only among
Hungarians but among other Caucasian populations.
An interesting, unexpected finding of our study was
the identification of a novel mutation, the ADH1B
Arg370His (rs75967634), and assessed its frequency.
This polymorphic sequence has already been submitted
into the PubMed’s SNP database, but without any infor-
mation on the population studied, its frequency, or pos-
sible effects. Because of its close proximity to ADH1B
Arg370Cys, it cannot be detected with either the origi-
nal hybridization probe assay [33] or with newer meth-
ods such as Illumina GoldenGate or Sequenom Mas-
sArray techniques and RFLP. A highly specific melting
point analysis as used in this study is required to detect
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it. Although we did not find any significant association
with alcohol drinking habits and liver diseases, there
may be possible associations that could not be identi-
fied in the present study because of its low prevalence.
Consequently, the effect of this SNP needs further in-
vestigation, including studies in other populations.
The results for ADH1B Arg48His in the samples
used in this study show concordance with the findings
of our previous study [22], as was expected.
The two main polymorphisms of ADH1C, the
Arg272Gln and Ile350Val have an almost complete
linkage between each other, as it was expected from
previous studies [34]. However, the results regard-
ing the effect of these mutations are not so obvious
among Caucasians. Although previous meta-analyses
and other studies [8,9,13,14] did not find an association
between these alleles and alcoholism or liver disease,
some researchers have described associations with al-
cohol drinking habits and/or alcoholism among Eu-
ropeans [18,30,32]. However, while our results con-
firm the lack of association with CLDs, we did find a
significantly increased OR for problem drinking (i.e.
positive CAGE status) and heavy drinking in ADH1C
272Gln/350Val homozygous patients. This ambiguity
may be due to the differences in categorizing drinking
habits in different studies and the relativelyminor effect
of this genotype. Our results of the linkage disequilib-
rium completely concur with previous studies [11,14,
18], which showed that ADH1B 48His allele is associ-
ated with the Arg272/Ile350 ADH1C allele.
To clarify the independent effect of the main poly-
morphisms of ADH1B and ADH1C, a multivariate
analysis was conducted. When CLD and alcohol use
habits were used as an outcome variable without con-
trolling for each other, the results were what were ex-
pected on the basis of the single SNP analysis, except
that being heterozygous for the ADH1B 48His allele
did not reduce the odds of problem drinking. This can
be due that this allele has an adverse effect on CAGE
status in cases and controls, e.g. in cases it did not
proved to be protective against CAGE positivism (p =
0.371). Combined with the relatively low number of
subjects in these categories it can result in the lack of
significant association.
Interestingly, when CAGE status was used as an out-
come variable and adjustment was made for the pres-
ence of CLD, only the association with homozygous
ADH1BArg48 status remained significant. WhenCLD
was the outcome variable and CAGE status was con-
trolled for, the association with carriage of ADH1B
48His and homozygous for ADH1C Arg272/Ile350 re-
mained significant. These results suggest that it is rea-
sonable to suppose that the polymorphisms of ADH1C
have a direct impact only on drinking habits. The out-
come of the single SNP analyses also supports this hy-
pothesis. On the contrary, while the ADH1B 48His
allele seemed to impact only on drinking habits on
the basis of previous individual analyses [22], these
results suggest that the absence of the controversial
ADH1C272Gln/350Val alleles are significantly protec-
tive against chronic liver disease. This is also supported
by the significantly protective effect against CLDs of
the group that was heterozygous for ADH1B 48His al-
lele and homozygous for ADH1C Arg272/Ile350 alle-
les in non-alcoholics (i.e. negativeCAGE status). How-
ever, this hypothesis needs to be confirmed by enzymat-
ic tests to assess enzyme activity and the consequent
alcohol elimination rate in subjects with these allelic
combinations or by other case-control studies involving
non-alcoholic cases and controls as well.
It is important to recognize that our study may un-
derestimate the real effect of the genotypes studied as
we have no data about individuals who have stopped
drinking after being diagnosed with liver disease. Nev-
ertheless, this work represents an important step in de-
termining the genetic background of alcoholism and
chronic liver diseases in Caucasians as it is one of the
most complex studies conducted in Europe, involving
a remarkably high number of cases and controls and
yielding novel and interesting findings, including new
interactions between ADH SNPs, alcohol dependence
and CLDs.
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